Champions Oncology
Han Ong is an accomplished professional in the field of oncology and tropical diseases with extensive experience in managing preclinical studies. Currently serving as Study Director at Champions Oncology, Inc. since November 2020, Han Ong is responsible for coordinating and executing studies tailored to external collaborators. Prior to this role, Han Ong held a similar position at Crown Bioscience, Inc. between November 2019 and August 2020. Han Ong's academic background includes a PhD in Life Sciences and a BSc (Hons) in Biochemistry from the University of Dundee, complemented by a Diploma in Biotechnology from Ngee Ann Polytechnic. Notable research experience includes a Postdoctoral Fellowship at the Wellcome Trust Sanger Institute focusing on vaccine candidates for visceral leishmaniasis, and earlier work at the University of Dundee targeting metabolic pathways in neglected tropical diseases.
This person is not in any teams
This person is not in any offices
Champions Oncology
Champions Oncology provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.